Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Nrx pharmaceuticals inc source : Www.biospace.com save search
NRx Pharmaceuticals, Inc. Announces New Data on NRX-101
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: -0.93%
H: 0.94%
C: -1.88%
nrx-101
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 1.17%
H: 0.29%
C: -5.41%
htx-100 pharmaceuticals
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 895.97%
H: 14.34%
C: 11.7%
business year update pharmaceuticals financial results
NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million
Published: 2024-02-27 (Crawled : 14:30) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: -31.5%
H: 5.02%
C: 0.38%
million offering
NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024
Published: 2024-02-26 (Crawled : 16:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 6.89%
H: 0.81%
C: -9.08%
ceo conference hope pharmaceuticals
NRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: -0.45%
H: 5.36%
C: -4.01%
ceo conference hope pharmaceuticals
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
Published: 2024-01-22 (Crawled : 15:30) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 5.93%
H: 8.89%
C: -2.76%
nrx-101 depression treatment trial
NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance with Nasdaq MVLS Standard
Published: 2024-01-02 (Crawled : 13:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 0.0%
H: 14.61%
C: 8.48%
nasdaq pharmaceuticals
NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression
Published: 2023-12-19 (Crawled : 14:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: -4.99%
H: 10.0%
C: -2.48%
ketamine depression treatment pharmaceuticals agreement
NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug (IND) Application for NRX-101 in the Treatment of Complicated Urinary Tract Infections
Published: 2023-12-18 (Crawled : 14:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 29.38%
H: 8.76%
C: -4.01%
nrx-101 fda drug treatment clearance pharmaceuticals application infections
NRx Pharmaceuticals to Participate in LifeSci Corporate Access Event
Published: 2023-12-11 (Crawled : 14:30) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 2.56%
H: 2.35%
C: -2.94%
pharmaceuticals
NRx Pharmaceuticals Announces Signing of a Development Agreement for the Manufacture of Ketamine to Treat Suicidality and Depression
Published: 2023-10-31 (Crawled : 12:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 0.0%
H: 0.21%
C: -1.52%
ketamine depression treat pharmaceuticals agreement
NRx Pharmaceuticals Announces Further Alignment with FDA on Initiation of Registrational Trials for NRX-101 in the Treatment of Chronic Pain
Published: 2023-10-26 (Crawled : 13:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 6.52%
H: 3.04%
C: 0.18%
nrx-101 fda treatment pharmaceuticals trials
NRx Pharmaceuticals Announces Strategic Change in Development of NRX-100 (IV Ketamine) at Dawson James Small Cap Investor Conference
Published: 2023-10-12 (Crawled : 12:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 3.38%
H: 5.44%
C: 3.06%
nrx-100 conference change pharmaceuticals
NRx Pharmaceuticals to Present at 8th Annual Dawson James Conference
Published: 2023-10-05 (Crawled : 19:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 0.0%
H: 2.5%
C: -1.79%
conference pharmaceuticals
NRx Pharmaceuticals Announces FDA Permission to Proceed on Investigational New Drug (IND) Application for NRX-101 to Treat Chronic Pain
Published: 2023-10-02 (Crawled : 19:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 4.81%
H: 5.72%
C: 5.36%
nrx-101 fda drug permission treat pharmaceuticals application
NRx Pharmaceuticals to Present at the Sidoti Virtual Small Cap Conference
Published: 2023-09-18 (Crawled : 12:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: -2.42%
H: 0.68%
C: -7.48%
conference pharmaceuticals
NRX Pharmaceuticals Announces Data Sharing Agreement Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Bipolar Depression
Published: 2023-09-15 (Crawled : 19:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 2.44%
H: 16.04%
C: 7.55%
ketamine depression treatment pharmaceuticals agreement
NRx Pharmaceuticals Announces Potent Antibacterial Activity of NRX-101 Against Common, Antibiotic Resistant Urinary Pathogens
Published: 2023-09-06 (Crawled : 18:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: -1.71%
H: 12.22%
C: -1.15%
nrx-101 antibacterial pharmaceuticals pathogens
NRx Pharmaceuticals Announces Submission of an Investigational New Drug (IND) Application for NRX-101 in the Treatment of Chronic Pain
Published: 2023-08-30 (Crawled : 12:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: -0.78%
H: 0.0%
C: -3.94%
nrx-101 drug treatment pharmaceuticals application submission
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.